Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

NCT01064505 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Optic Atrophy
Non-arteritic Anterior Ischemic Optic Neuropathy

Interventions

DRUG: QPI-1007 at various doses

Sponsor

Quark Pharmaceuticals